| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |